Brainstorm Cell Therapeutics Inc. (BCLI)

NASDAQ: BCLI · IEX Real-Time Price · USD

0.353

-0.004 (-1.12%)

At close: Jul 2, 2024, 4:00 PM

0.358

+0.005 (1.30%)

After-hours: Jul 2, 2024, 7:50 PM EDT

BCLI Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2007
Market Capitalization	25	13	60	145	143	97	Upgrade
Market Cap Growth	-77.15%	-77.69%	-58.70%	1.59%	47.63%	31.62%	Upgrade
Enterprise Value	26	13	61	128	108	99	Upgrade
PE Ratio	-	-0.78	-2.47	-5.93	-4.49	-4.16	Upgrade
PB Ratio	-4.98	-2.75	-19.88	7.50	4.03	-7.92	Upgrade
P/FCF Ratio	-1.41	-0.65	-3.10	-5.46	-4.02	-8.26	Upgrade
P/OCF Ratio	-1.42	-0.65	-3.10	-5.52	-4.06	-8.60	Upgrade
EV/EBITDA Ratio	-1.90	-0.81	-2.49	-5.29	-3.44	-4.32	Upgrade
EV/EBIT Ratio	-1.87	-0.80	-2.46	-5.24	-3.41	-4.28	Upgrade
EV/FCF Ratio	-1.43	-0.65	-3.15	-4.82	-3.04	-8.41	Upgrade
Debt / Equity Ratio	-0.20	-0.26	-1.36	0.26	0.20	-0.19	Upgrade
Debt / EBITDA Ratio	-0.08	-0.08	-0.17	-0.21	-0.23	-0.10	Upgrade
Debt / FCF Ratio	-0.06	-0.06	-0.21	-0.19	-0.20	-0.20	Upgrade
Quick Ratio	0.12	0.17	0.35	3.51	3.76	0.17	Upgrade
Current Ratio	0.18	0.24	0.35	3.69	3.85	0.19	Upgrade
Interest Coverage	-27.82	-37.46	-	-	-249.48	-91.27	Upgrade
Return on Equity (ROE)	368.30%	425.50%	-468.90%	-88.40%	-158.50%	401.10%	Upgrade
Return on Assets (ROA)	-327.30%	-292.50%	-146.10%	-63.30%	-105.00%	-265.30%	Upgrade
Return on Capital (ROIC)	423.62%	598.35%	-2302.60%	-100.48%	-74.23%	233.35%	Upgrade
Earnings Yield	-61.41%	-128.57%	-40.51%	-16.85%	-22.27%	-24.03%	Upgrade
FCF Yield	-77.29%	-153.13%	-32.29%	-18.33%	-24.90%	-12.11%	Upgrade
Buyback Yield / Dilution	-76.23%	-17.99%	-0.90%	-21.22%	-36.25%	-9.54%	Upgrade
Total Shareholder Return	-76.23%	-17.99%	-0.90%	-21.22%	-36.25%	-9.54%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).